These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 8861401

  • 61. Response to day hospital treatment by patients with cocaine and alcohol dependence.
    Alterman AI, Droba M, McLellan AT.
    Hosp Community Psychiatry; 1992 Sep; 43(9):930-2. PubMed ID: 1427705
    [No Abstract] [Full Text] [Related]

  • 62. Gender differences in predictors of treatment attrition with high dose naltrexone in cocaine and alcohol dependence.
    Suh JJ, Pettinati HM, Kampman KM, O'Brien CP.
    Am J Addict; 2008 Sep; 17(6):463-8. PubMed ID: 19034737
    [Abstract] [Full Text] [Related]

  • 63. Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence.
    Sofuoglu M, Gonzalez G, Poling J, Kosten TR.
    Am J Drug Alcohol Abuse; 2003 Sep; 29(4):713-27. PubMed ID: 14713135
    [Abstract] [Full Text] [Related]

  • 64. Desipramine treatment for cocaine dependence. Role of antisocial personality disorder.
    Arndt IO, McLellan AT, Dorozynsky L, Woody GE, O'Brien CP.
    J Nerv Ment Dis; 1994 Mar; 182(3):151-6. PubMed ID: 8113775
    [Abstract] [Full Text] [Related]

  • 65. Repeat users of substance abuse services at a VA Medical Center.
    Hartz DT, Banys P, Hall SM.
    Psychiatr Serv; 1995 Mar; 46(3):285-7. PubMed ID: 7796220
    [Abstract] [Full Text] [Related]

  • 66. Underreporting of cocaine use at posttreatment follow-up and the measurement of treatment effectiveness.
    Lundy A, Gottheil E, McLellan AT, Weinstein SP, Sterling RC, Serota RD.
    J Nerv Ment Dis; 1997 Jul; 185(7):459-62. PubMed ID: 9240365
    [Abstract] [Full Text] [Related]

  • 67. Cocaine abstinence symptomatology and treatment attrition.
    Mulvaney FD, Alterman AI, Boardman CR, Kampman K.
    J Subst Abuse Treat; 1999 Mar; 16(2):129-35. PubMed ID: 10023610
    [Abstract] [Full Text] [Related]

  • 68. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
    Stenbacka M, Beck O, Leifman A, Romelsjö A, Helander A.
    Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
    [Abstract] [Full Text] [Related]

  • 69. Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost.
    Avants SK, Margolin A, Sindelar JL, Rounsaville BJ, Schottenfeld R, Stine S, Cooney NL, Rosenheck RA, Li SH, Kosten TR.
    Am J Psychiatry; 1999 Jan; 156(1):27-33. PubMed ID: 9892294
    [Abstract] [Full Text] [Related]

  • 70. An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence.
    Rothman RB, Gorelick DA, Heishman SJ, Eichmiller PR, Hill BH, Norbeck J, Liberto JG.
    J Subst Abuse Treat; 2000 Apr; 18(3):277-81. PubMed ID: 10742642
    [Abstract] [Full Text] [Related]

  • 71. Psychosocial and clinical predictors of retention in outpatient alcoholism treatment.
    Corrêa Filho JM, Baltieri DA.
    Braz J Psychiatry; 2012 Dec; 34(4):413-21. PubMed ID: 23429812
    [Abstract] [Full Text] [Related]

  • 72. Self-reported depression as a predictor of dropout in a hierarchical therapeutic community.
    Ravndal E, Vaglum P.
    J Subst Abuse Treat; 1994 Dec; 11(5):471-9. PubMed ID: 7869469
    [Abstract] [Full Text] [Related]

  • 73. Effectiveness and costs of inpatient versus day hospital cocaine rehabilitation.
    Alterman AI, O'Brien CP, McLellan AT, August DS, Snider EC, Droba M, Cornish JW, Hall CP, Raphaelson AH, Schrade FX.
    J Nerv Ment Dis; 1994 Mar; 182(3):157-63. PubMed ID: 8113776
    [Abstract] [Full Text] [Related]

  • 74. Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled double-blind trials.
    Grabowski J, Rhoades H, Elk R, Schmitz J, Davis C, Creson D, Kirby K.
    J Clin Psychopharmacol; 1995 Jun; 15(3):163-74. PubMed ID: 7635993
    [Abstract] [Full Text] [Related]

  • 75. Concurrent validity of cocaine and sedative dependence diagnoses in opioid-dependent outpatients.
    Kidorf M, Brooner RK, King VL, Chutuape MA, Stitzer ML.
    Drug Alcohol Depend; 1996 Oct; 42(2):117-23. PubMed ID: 8889410
    [Abstract] [Full Text] [Related]

  • 76. Serum prolactin and response to treatment among cocaine-dependent individuals.
    Patkar AA, Hill KP, Sterling RC, Gottheil E, Berrettini WH, Weinstein SP.
    Addict Biol; 2002 Jan; 7(1):45-53. PubMed ID: 11900622
    [Abstract] [Full Text] [Related]

  • 77. A delta-opioid receptor genetic variant is associated with abstinence prior to and during cocaine dependence treatment.
    Crist RC, Doyle GA, Kampman KM, Berrettini WH.
    Drug Alcohol Depend; 2016 Sep 01; 166():268-71. PubMed ID: 27449273
    [Abstract] [Full Text] [Related]

  • 78. The autonomy of mood disorders among cocaine-using methadone patients.
    Rosenblum A, Fallon B, Magura S, Handelsman L, Foote J, Bernstein D.
    Am J Drug Alcohol Abuse; 1999 Feb 01; 25(1):67-80. PubMed ID: 10078978
    [Abstract] [Full Text] [Related]

  • 79. The added risk of opioid problem use among treatment-seeking youth with marijuana and/or alcohol problem use.
    Subramaniam GA, Ives ML, Stitzer ML, Dennis ML.
    Addiction; 2010 Apr 01; 105(4):686-98. PubMed ID: 20403020
    [Abstract] [Full Text] [Related]

  • 80. The significance of a coexisting opioid use disorder in cocaine dependence: an empirical study.
    Weiss RD, Martínez-Raga J, Hufford C.
    Am J Drug Alcohol Abuse; 1996 May 01; 22(2):173-84. PubMed ID: 8727053
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.